Your browser doesn't support javascript.
loading
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
Modesto, Anouchka; Tougeron, David; Tremolières, Pierre; Ronchin, Philippe; Jouve, Ariane Darut; Leignel, Delphine Argo; Vendrely, Véronique; Riou, Olivier; Martin-Babau, Jérôme; Le Sourd, Samuel; Mirabel, Xavier; Leroy, Thomas; Huguet, Florence; Montaigne, Lucile; Baumgaertner, Isabelle; Deslandres, Marion; Moyal, Elizabeth; Seva, Catherine; Selves, Janick; Otal, Philippe; Pezzella, Veronica; Guimbaud, Rosine; Filleron, Thomas; Quéro, Laurent.
Afiliação
  • Modesto A; Radiation Oncology Department Institut Claudius Regaud at Institut, Universitaire du Cancer de Toulouse-Oncopole, 1 Rue Irene Joliot Curie, 31059, Toulouse, France. modesto.anouchka@iuct-oncopole.fr.
  • Tougeron D; Inserm Team 11 RadOpt CRCT 1, Avenue Hubert Curien, 31059, Toulouse, France. modesto.anouchka@iuct-oncopole.fr.
  • Tremolières P; Service d'hépato-Gastro-Entérologie, Centre Hospitalier Universitaire de Poitiers, 86000, Poitiers, France.
  • Ronchin P; Institut de Cancérologie de L'Ouest: Angers Et Saint Herblain, Saint-herblain, France.
  • Jouve AD; Hôpital Privé Arnault Tzanck- Centre Azuréen de Cancérologie, Mougins, France.
  • Leignel DA; Institut de Cancérologie de Bourgogne, Dijon, France.
  • Vendrely V; Groupe Hospitalier Bretagne Sud, Lorient, France.
  • Riou O; CHU de Bordeaux, Bordeaux, France.
  • Martin-Babau J; Centre Val d'Aurelle, Montpellier, France.
  • Le Sourd S; Centre Armoricain d'Oncologie CARIO, Plérin, France.
  • Mirabel X; Centre Eugène Marquis, Renne, France.
  • Leroy T; Centre Oscar Lambret, Lille, France.
  • Huguet F; Nouvelle Clinique Des Dentellières, Valenciennes, France.
  • Montaigne L; Radiation Oncology Department, Tenon Hospital, AP-HP,, Sorbonne University, Paris, France.
  • Baumgaertner I; Centre Antoine Lacassagne, Nice, France.
  • Deslandres M; Centre Hospitalo Universitaire Henri Mondor APHP, Créteil, France.
  • Moyal E; GI Oncology Department Centre Hospitalo, Universitaire Rangueil, Toulouse, France.
  • Seva C; Radiation Oncology Department Institut Claudius Regaud at Institut, Universitaire du Cancer de Toulouse-Oncopole, 1 Rue Irene Joliot Curie, 31059, Toulouse, France.
  • Selves J; Inserm Team 11 RadOpt CRCT 1, Avenue Hubert Curien, 31059, Toulouse, France.
  • Otal P; Inserm Team 11 RadOpt CRCT 1, Avenue Hubert Curien, 31059, Toulouse, France.
  • Pezzella V; Pathology department, Centre Hospitalo Universitaire IUCT-Oncopole, Toulouse, France.
  • Guimbaud R; Imaging Department Centre Hospitalo, Universitaire Rangueil, Toulouse, France.
  • Filleron T; UNICANCER, Paris, France.
  • Quéro L; GI Oncology Department Centre Hospitalo, Universitaire Rangueil, Toulouse, France.
BMC Cancer ; 23(1): 966, 2023 Oct 12.
Article em En | MEDLINE | ID: mdl-37828434
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França